RecruitingNCT07262190
NavSTAR Implementation Effectiveness study Across a Health System
This summary needs review. Please check the official study record and contact the research team for details.
In United StatesAddictionBehavioralOver 18 Years
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
RecruitingNCT06911112
NBI-1065845 for depression
This study is recruiting in the United States. It is testing NBI-1065845 for depression.
In United StatesDepressionDrugA study involving a medication or substance.Over 18 Years
RecruitingNCT06963021
NBI-1065845 for depression
This study is recruiting in the United States, in Canada, in the United Kingdom, .... It is testing NBI-1065845 for depression.
In United StatesDepressionDrugOver 18 Years
RecruitingNCT06963034
NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
This study is looking at care and outcomes for people with Schizophrenia. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
In United StatesSchizophreniaDrugFrom 18 Years to 65 Years
RecruitingNCT07105098
NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
This study is looking at care and outcomes for people with Schizophrenia. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
In United StatesSchizophreniaDrugFrom 18 Years to 65 Years
RecruitingNCT07114874
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
This study is looking at evaluate the long-term safety of NBI-1117568 in adults with schizophrenia. Taking part may give some people access to NBI-1117568, but direct benefit is not guaranteed.
In United StatesSchizophreniaDrugFrom 18 Years to 65 Years
RecruitingNCT04061148
Near Infrared Spectroscopy (NIRS) for Assessment of Depression
This study is comparing NIRSIT with Non-Depressed Controls for people with depression. Participants receive NIRSIT or Non-Depressed Controls and complete study visits and assessments.
In United StatesDepressionDeviceA study involving a tool, app, wearable, test, or medical device.Over 18 Years
RecruitingNCT06752759
Nebulized Ketamine for Major Depressive Disorder
This study is looking at assess if nebulized ketamine can reduce depressive symptoms for people with depression or anxiety. Participants receive a study treatment and complete follow-up visits and assessments.
Remote / onlineDepression, AnxietyDrugFrom 18 Years to 88 Years
RecruitingNCT07460973
Nen ŨnkUmbi/EdaHiYedo Plus (We Are Here Now Plus): a Multi-level Intervention to Reduce Health Disparities Among American Indian Youth
This study is recruiting in the United States. It focuses on Addiction.
In United StatesAddictionBehavioralFrom 12 Years to 18 Years
RecruitingNCT04929288
Neural and Hormonal Influences on Sex Differences in Risk for AUD
This summary needs review. Please check the official study record and contact the research team for details.
In United StatesAddictionDrugFrom 21 Years to 26 Years
RecruitingNCT06941298
Neural and Psychiatric Consequences of Cannabis Use in Adolescents
This study is looking at care and outcomes for people with Cannabis Use or Depression. Taking part may give some people access to Neuroimaging Investigation, but direct benefit is not guaranteed.
In United StatesDepressionBehavioralFrom 14 Years to 20 Years
RecruitingNCT05185128
Neural Basis of Social Cognition Deficits
This study is looking at whether PEERS social skills intervention can help people with Autism Spectrum Disorder, Psychosis, or Social Communication. Participants take part in PEERS social skills intervention and complete follow-up assessments.
In United StatesSchizophreniaBehavioralFrom 12 Years to 18 Years
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.